<DOC>
	<DOCNO>NCT01727843</DOCNO>
	<brief_summary>Tranexamic acid ( TA ) synthetic antifibrinolytic agent . It prevent degradation fibrin delay breakdown hemostatic clot . It demonstrate multiple study meta analysis decrease blood loss elective hip knee arthroplasty . However , concern prothrombotic side effect systemic administration TA hinder widespread adoption medication orthopaedic patient due high risk thrombotic complication deep venous thrombosis pulmonary embolism Topical application tranexamic acid propose way mitigate potential prothrombotic effect TA . Topical application TA demonstrate beneficial oral cardiac surgery . Plasma level TA find minimal follow topical application , minimize potential systemic thromboembolic side effect . TA use topically total knee arthroplasty , significant reduction blood loss increase thromboembolic complications8,10 . Data use TA hip fracture surgery limit , study examine topical use TA hip fracture surgery . Our study question : Does topical tranexamic acid decrease blood loss follow hemiarthroplasty hip femoral neck fracture ?</brief_summary>
	<brief_title>Topical Application Tranexamic Acid Postoperative Blood Loss Femoral Neck Fractures</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Femoral Neck Fractures</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>hip fracture patient age 65 old . bilateral femoral neck fracture patient and/or one suit hemiarthroplasty repair .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>fracture</keyword>
	<keyword>hip</keyword>
	<keyword>tranexamic acid</keyword>
	<keyword>topical</keyword>
</DOC>